S2P fundamentals
SIMCERE PHARMACEUTICAL GROUP LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of S2P for the last semiannual is 403.28 M EUR, and it's 0.32% lower compared to the previous semiannual. The net income of H1 24 is 59.14 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM